The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
Open accessAbstract
Amplicon-based next-generation sequencing (NGS) of immunoglobulin (IG) and T-cell receptor (TR) gene rearrangements for clonality assessment, marker identification and quantification of minimal residual disease (MRD) in lymphoid neoplasms has been the focus of intense research, development and application. However, standardization and validation in a scientifically controlled multicentre setting is still lacking. Therefore, IG/TR assay development and design, including bioinformatics, was performed within the EuroClonality-NGS working group and validated for MRD marker identification in acute lymphoblastic leukaemia (ALL). Five EuroMRD ALL reference laboratories performed IG/TR NGS in 50 diagnostic ALL samples, and compared results with those generated through routine IG/TR Sanger sequencing. A central polytarget quality control (cPT-QC) was used to monitor primer performance, and a central in-tube quality control (cIT-QC) was spiked into each sample as a library-specific quality control and calibrator. NGS identified 259 (average 5.2/sample, range 0-14) clonal sequences vs. Sanger-sequencing 248 (average 5.0/sample, range 0-14). NGS primers covered possible IG/TR rearrangement types more completely compared with local multiplex PCR sets and enabled sequencing of bi-allelic rearrangements and weak PCR products. The cPT-QC showed high reproducibility across all laboratories. These validated and reproducible quality-controlled EuroClonality-NGS assays can be used for standardized NGS-based identification of IG/TR markers in lymphoid malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer3 on the WWW for General Users and for Biologist Programmers
Rozen, S., & Skaletsky, H. (2003) · Bioinformatics Methods and Protocols · doi:10.1385/1-59259-192-2:365 · Cited by 15,013
Somatic generation of antibody diversity
Tonegawa, S. (1983) · Nature · doi:10.1038/302575a0 · Cited by 4,005
Somatic generation of antibody diversity.
Matthyssens, G., Hozumi, N., & Tonegawa, S. (1976) · PubMed · Cited by 3,244
T-cell antigen receptor genes and T-cell recognition
Davis, M. M., & Bjorkman, P. J. (1988) · Nature · doi:10.1038/334395a0 · Cited by 3,202
van Dongen, J. J. M., Langerak, A. W., Brüggemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., García-Sanz, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403202 · Cited by 3,043
Self-citationPrognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
van Dongen, J. J., Seriu, T., Panzer-Grümayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04058-6 · Cited by 952
Self-citationvan der Velden, V. H. J., Cazzaniga, G., Schrauder, A., Hancock, J., Bader, P., Panzer-Grumayer, E. R., Flohr, T., Sutton, R., Cave, H., Madsen, H. O., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404586 · Cited by 701
Self-citationIMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes
Giudicelli, V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki010 · Cited by 546
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Faham, M., Zheng, J., Moorhead, M., Carlton, V. E. H., Stow, P., Coustan-Smith, E., Pui, C.-H., & Campana, D. (2012) · Blood · doi:10.1182/blood-2012-07-444042 · Cited by 423
High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire
DeKosky, B. J., Ippolito, G. C., Deschner, R. P., Lavinder, J. J., Wine, Y., Rawlings, B. M., Varadarajan, N., Giesecke, C., Dörner, T., Andrews, S. F., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2492 · Cited by 410
Boyd, S. D., Marshall, E. L., Merker, J. D., Maniar, J. M., Zhang, L. N., Sahaf, B., Jones, C. D., Simen, B. B., Hanczaruk, B., Nguyen, K. D., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000540 · Cited by 386
Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing
Freeman, J. D., Warren, R. L., Webb, J. R., Nelson, B. H., & Holt, R. A. (2009) · Genome Research · doi:10.1101/gr.092924.109 · Cited by 385
Overlap and Effective Size of the Human CD8 + T Cell Receptor Repertoire
Robins, H. S., Srivastava, S. K., Campregher, P. V., Turtle, C. J., Andriesen, J., Riddell, S. R., Carlson, C. S., & Warren, E. H. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001442 · Cited by 383
Giudicelli, V., Brochet, X., & Lefranc, M.-P. (2011) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5633 · Cited by 379
Lefranc, M., & Lefranc, M. (2001) · Cited by 367
Ladetto, M., Brüggemann, M., Monitillo, L., Ferrero, S., Pepin, F., Drandi, D., Barbero, D., Palumbo, A., Passera, R., Boccadoro, M., et al. (2014) · Leukemia · doi:10.1038/leu.2013.375 · Cited by 304
Self-citationCheckpoints in lymphocyte development and autoimmune disease
von Boehmer, H., & Melchers, F. (2010) · Nature Immunology · doi:10.1038/ni.1794 · Cited by 285
Wu, Y.-C., Kipling, D., Leong, H. S., Martin, V., Ademokun, A. A., & Dunn-Walters, D. K. (2010) · Blood · doi:10.1182/blood-2010-03-275859 · Cited by 283
Wang, C., Sanders, C. M., Yang, Q., Schroeder, H. W., Wang, E., Babrzadeh, F., Gharizadeh, B., Myers, R. M., Hudson, J. R., Davis, R. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913939107 · Cited by 263
(2001) · Elsevier eBooks · doi:10.1016/b978-0-12-441352-8.x5000-0 · Cited by 240
Brüggemann, M., White, H., Gaulard, P., Garcia-Sanz, R., Gameiro, P., Oeschger, S., Jasani, B., Ott, M., Delsol, G., Orfao, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404481 · Cited by 240
Self-citationHigh-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia
Wu, D., Sherwood, A., Fromm, J. R., Winter, S. S., Dunsmore, K. P., Loh, M. L., Greisman, H. A., Sabath, D. E., Wood, B. L., & Robins, H. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003656 · Cited by 237
Pulsipher, M. A., Carlson, C., Langholz, B., Wall, D. A., Schultz, K. R., Bunin, N., Kirsch, I., Gastier-Foster, J. M., Borowitz, M., Desmarais, C., et al. (2015) · Blood · doi:10.1182/blood-2014-12-615757 · Cited by 225
Regulating antigen-receptor gene assembly
Schlissel, M. S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1225 · Cited by 168
Logan, A. C., Gao, H., Wang, C., Sahaf, B., Jones, C. D., Marshall, E. L., Buño, I., Armstrong, R., Fire, A. Z., Weinberg, K. I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118357109 · Cited by 167
Fate Decisions Regulating Bone Marrow and Peripheral B Lymphocyte Development
Monroe, J. G., & Dorshkind, K. A. (2007) · Advances in immunology · doi:10.1016/s0065-2776(07)95001-4 · Cited by 149
Logan, A. C., Zhang, B. M., Narasimhan, B., et al. (2013) · Leukemia · doi:10.1038/leu.2013.52 · Cited by 134
Gawad, C., Pepin, F., Carlton, V. E. H., Klinger, M., Logan, A. C., Miklos, D. B., Faham, M., Dahl, G. V. H., & Lacayo, N. J. (2012) · Blood · doi:10.1182/blood-2012-05-429811 · Cited by 125
Vidjil: A Web Platform for Analysis of High-Throughput Repertoire Sequencing
Duez, M., Giraud, M., Herbert, R., Rocher, T., Salson, M., & Thonier, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166126 · Cited by 105
Self-citationon behalf of the EuroClonality-NGS Working Group, Knecht, H., Reigl, T., Kotrová, M., Appelt, F., Stewart, P., Bystrý, V., Krejčí, A., Grioni, A., Pál, K., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0499-4 · Cited by 91
Self-citationMFEprimer-2.0: a fast thermodynamics-based program for checking PCR primer specificity
Qu, W., Zhou, Y., Zhang, Y., Lu, Y., Wang, X., Zhao, D., Yang, Y., & Zhang, C. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks552 · Cited by 88
Langerak, A. W., Brüggemann, M., Davi, F., Darzentas, N., van Dongen, J. J. M., de Castro, D. G., Cazzaniga, G., Giudicelli, V., Lefranc, M., Giraud, M., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602050 · Cited by 73
Self-citationde Haas, V., Verhagen, O. J. H. M., Borne, A. V. D., Kroes, W. G. M., van den Berg, H., & van der Schoot, C. E. (2001) · Leukemia · doi:10.1038/sj.leu.2401970 · Cited by 62
Kotrová, M., Trka, J., Kneba, M., & Brüggemann, M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0277-9 · Cited by 56
Self-citationLefranc, M., & Lefranc, G. (2001) · Elsevier eBooks · doi:10.1016/b978-012441352-8/50008-4 · Cited by 43
Cited by
Schultheiß, C., Paschold, L., Simnica, D., Mohme, M., Willscher, E., von Wenserski, L., Scholz, R., Wieters, I., Dahlke, C., Tolosa, E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.024 · Cited by 333
Magnani, A., Semeraro, M., Adam, F., Booth, C., Dupré, L., Morris, E. C., Gabrion, A., Roudaut, C., Borgel, D., Toubert, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01641-x · Cited by 128
Self-citation
Metadata
- Authors
- on behalf of the EuroClonality-NGS working group, Brüggemann, M., Kotrová, M., Knecht, H., Bartram, J., Boudjogrha, M., Bystry, V., Fazio, G., Froňková, E., Giraud, M., Grioni, A., Hancock, J., Herrmann, D., Jiménez, C., Krejci, A., Moppett, J., Reigl, T., Salson, M., Scheijen, B., Schwarz, M., Songia, S., Svaton, M., van Dongen, J. J. M., Villarese, P., Wakeman, S., Wright, G., Cazzaniga, G., Davi, F., García-Sanz, R., Gonzalez, D., Groenen, P. J. T. A., Hummel, M., Macintyre, E. A., Stamatopoulos, K., Pott, C., Trka, J., Darzentas, N., & Langerak, A. W.
- Venue
- Leukemia
- Published
- 2019-06-26
- Volume
- 33
- Issue
- 9
- Pages
- 2241-2253
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2954189331
- Cited by
- 264
- References
- 35
- FWCI
- 25.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.